CDKN2A and astrocytoma (excluding glioblastoma): Although grade 2 or 3 tumors are stratified according to anaplasia or mitotic activity, definitive grading for CDKN2A/B-intact astrocytoma, IDH-mutant remains challenging because of differences in inter-rater consensus [5].